A breast cancer risk assessment can help determine whether your family history calls for genetic counselling, earlier mammography, or breast MRI. One relative with breast cancer does not automatically mean you need extra screening: the number of relatives affected, their ages at diagnosis, and related cancers in the family all matter. If you have a new breast symptom, seek assessment rather than waiting for your next screening appointment.
Which Family Histories Deserve A Closer Look?
Patterns that may prompt formal assessment include several close relatives with breast cancer, diagnoses at younger ages, male breast cancer, or a combination of breast and ovarian cancer. Bilateral breast cancer—cancer in both breasts—can also be relevant, particularly when diagnosed at a younger age. These patterns can raise the possibility of an inherited cancer predisposition, but they do not prove that you carry an inherited variant.
Referral criteria vary. In the UK, the NHS National Genomics Education Programme describes referral patterns including a first-degree relative diagnosed before 40, a male first-degree relative with breast cancer, or multiple relatives with breast or ovarian cancer. By contrast, an isolated female relative diagnosed after 40, without associated cancers or other flagged features, may be considered near population risk in that pathway. That is one national approach, not a universal rule.
Write down which relatives were affected, what cancers they had, and their ages at diagnosis. If you do not know some details, say so. A clinician can use what is known to decide whether a specialist family-history review or genetic counselling is appropriate.
When A breast cancer risk assessment Can Change Screening
A risk assessment brings family history together with other relevant information to estimate risk. Tools such as Tyrer-Cuzick (also called IBIS) and the Gail model use different combinations of factors; their scores are not genetic test results or diagnoses. A risk model can support a screening discussion, but a number from an online breast cancer risk calculator is not, by itself, a screening plan.
Some US guidance uses a modeled lifetime risk above 20% as a threshold for annual breast MRI alongside mammography. The appropriate starting age depends on why your risk is elevated and on the guideline being followed. People with a known high-risk genetic variant or certain histories of chest radiation may follow a different pathway. Ask which model was used, what information went into it, and how its result changes your recommended screening.
Earlier mammography is not automatically helpful just because a relative was diagnosed young. A US study by Danielle D. Durham and colleagues examined 74,838 first screening mammograms recorded by three Breast Cancer Surveillance Consortium registries in North Carolina, San Francisco, and Vermont from 1996 to 2016. Women reporting a first-degree relative with breast cancer were more likely to start before 40 than women reporting none. The study measured screening patterns, not whether earlier screening improved outcomes. It therefore cannot establish that starting ten years before a relative’s diagnosis is beneficial; the researchers noted that direct evidence for this approach without a known genetic mutation was lacking.
Why Screening Plans Differ By Country
There is no single screening schedule used worldwide. In a 2022 systematic review, Wenhui Ren and colleagues compared 23 guidelines issued in 11 countries or regions between 2010 and 2021. Recommendations differed in starting age, interval, and imaging method. The review found broad agreement that people at higher risk may need screening earlier, often with annual mammography or MRI, but it did not establish one schedule for every country.
For example, US guidance summarized in a 2024 clinical review describes annual MRI alongside mammography for some people whose modeled lifetime risk exceeds 20%. In the UK, family-history assessment and referral follow a national pathway. Rules and access can differ elsewhere, including across Europe and Australia, so do not assume that a threshold or starting age used in one country applies where you live. Ask your local breast screening service or clinician how your risk is assessed and which guideline informs the plan.
Symptoms Are Not A Screening Question
Screening is for people without symptoms. A new lump, nipple change, skin change, or other concerning breast symptom needs clinical assessment even if your next mammogram is not due—or you have recently had a normal screening result. Contact a healthcare professional promptly rather than waiting for your scheduled screen.